Shanghai Facility

ACTIVITY

  • Research, development, manufacturing and  marketing of recombinant biopharmaceutical products (APIs & FDFs)
  • Manufacturing operations span across 5 units, 3 dedicated to APIs and 2 dedicated to FDFs, including a new production line for monoclonal antibodies (mAbs)
  • 20,000 m² manufacturing facility

Chemo Wan Bang

1098 yuegong Rd, Jinshan Industrial Zone
Shanghai, China.

Phone: +86 18-626009588

zhouyc@chemowabang.cn
http://www.exeltis.com.cn/